Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies
Timothée Bruel, Jérôme Hadjadj, Piet Maes, Delphine Planas, Aymeric Sève, Isabelle Staropoli, Florence Guivel‐Benhassine, Françoise Porrot, William Bolland, Yann Nguyen, Marion Casadevall, Caroline Charre, Hélène Péré, David Veyer, Matthieu Prot, Artem Baidaliuk, Lize Cuypers, Cyril Planchais, Hugo Mouquet, Guy Baele, Luc Mouthon, Laurent Hocqueloux, Etienne Simon‐Lorière, Emmanuel André, Benjamin Terrier, Thiérry Prazuck, Olivier Schwartz
Topics & Concepts
NeutralizationMonoclonal antibodyVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakAntibodyMedicineBiologyImmunologyVirusInfectious disease (medical specialty)PathologyOutbreakDiseaseSARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies ResearchImmunotherapy and Immune Responses